Cancer screening to detect before symptoms appear. This involve blood tests, urine tests, DNA tests other tests, or medical imaging. The benefits of screening terms of cancer prevention, early detection and subsequent treatment must be weighed against any harm. Since screening diseases find at an early stage, there may be a better chance of curing the disease. Examples of cancer screening tests are the mammogram for breast cancer, colonoscopy for colon cancer, and the Pap test and HPV tests for cervical cancer. Screening can also include a genetic test to check for a person’s risk of developing an inherited disease.
Screening tests must be effectively, safe, well-tolerated with acceptably low rates of false positive and false negative results. If cancer is detected, more definitive and invasive follow-up tests are performed to reach a diagnosis. Screening can lead to cancer prevention and earlier diagnosis. Early diagnostics may lead to higher rates of successful treatment and extended life. However, it may also appear to increase the time to death through lead time bias or length time bias.
• Diagnosis cancer
Related Cancer Screening Conferences | Cancer Screening Conferences 2020 | Cancer Screening Congress | Cancer Screening Congress 2020 | Cancer Screening Meetings | Cancer Screening Meetings 2020 | Cancer Screening Events | Cancer Screening Events 2020
Related Cancer Diagnosis Conferences | Cancer Diagnosis Conferences 2020 | Cancer Diagnosis Congress | Cancer Diagnosis Congress 2020 | Cancer Diagnosis Meetings | Cancer Diagnosis Meetings 2020 | Cancer Diagnosis Events | Cancer Diagnosis Events 2020
Engineering Next-Generation Cancer Immunotherapies, San Diego, CA, United States; International Lung Cancer Congress, Huntington Beach, CA, United States; 16th Annual Conference of The Hematology Oncology Pharmacy Association, Tampa, FL, United States; Mayo Clinic Radiation Oncology: Current Practice and Future Direction 2020,Waimea, Hi, United States
Hellenic Neuro Oncology Group, Italian Association of Neuro-Oncology, National Cancer Research Institute, Neurooncology Working Group of the German Cancer Society, Serbian Neurooncology Society, SNO Society of Neuro Oncology, Society for Neurooncology Sub-Sahara Africa, Mexican Society of Oncology, Myanmar Oncology Society, Dutch Society for Medical Oncology